𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy

✍ Scribed by Heinz, R.

Publisher
Springer-Verlag
Year
1990
Weight
861 KB
Volume
60
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term follow-up of patients receivin
Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas
✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; Ronald P. Ng πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 1 views

This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and

Long-term follow-up of patients with int
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone
✍ Fausto Rossini; Elisabetta Terruzzi; Daniele Perego; Isabella Miccolis; Franca R πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Doxorubicin cardiotoxicity is one of the most serious side effects of the cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, regimen, especially among elderly patients. In the CEOP regimen, epirubicin was substituted for doxorubicin to reduce cardiot

Long term follow-up and late complicatio
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma
✍ Lynn R. Kong; Cheng-Fang Huang; David Hakimian; Daina Variakojis; Leonard Klein; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 2 views

## Background: The aim of this study was to determine the long term outcome and toxicities after the administration of 2-chlorodeoxyadenosine (2-cda) to patients with previously treated, advanced, indolent non-hodgkin's lymphoma (nhl). ## Methods: Twenty-two patients (median age, 55 years) with r

Long term follow-up and late complicatio
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma
✍ Meral BeksaΓ§; Mutlu Arat; Ramazan Idilman πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as

Clinical and prognostic heterogeneity of
Clinical and prognostic heterogeneity of non-hodgkin lymphomas of high-grade malignancy
✍ Schmalhorst, U. ;Bartels, H. ;Boll, I. ;Burger-SchοΏ½ler, A. ;Common, H. ;FοΏ½lle, H πŸ“‚ Article πŸ“… 1981 πŸ› Springer-Verlag βš– 603 KB

Comparison of clinical data of 64 patients with centroblastic lymphoma, 55 patients with immunoblastic lymphoma and 31 patients with lymphoblastic lymphoma not only confirmed the original assumption of high-grade malignancy as proposed by the concept of the Kiel classification but also demonstrated